Clinical trial
Photodynamic Therapy in Treating Patients With Precancerous Esophageal…
NCT00281736 · Roswell Park Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00281736 |
|---|---|
| Title | Photodynamic Therapy in Treating Patients With Precancerous Esophageal Conditions or Early Stage Esophageal Cancer |
| Official title | A Phase II Study of HPPH Photodynamic Therapy for Treatment of High Grade Dysplasia, Carcinoma In-Situ or Early Intramucosal Adenocarcinoma in Barrett's Esophagus. Randomization to Two PDT Treatment Regimens of HPPH (2-1 [Hexyloxyethyl]-2devinylpyropheophorbide-a) and Light |
| Lead sponsor | Roswell Park Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer, Precancerous Condition |
| Intervention type | Drug |
| Interventions | HPPH |
| Enrollment | 60 |
| Start date | Feb 1, 2004 |
| Primary completion | Jul 1, 2007 |
| Completion | Dec 1, 2013 |
| First posted | Jan 25, 2006 |
| Last update posted | Jan 3, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: